title: Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Ronchetti
authors.forename: Françoise
authors.initials: F
authors.lastname: Isnard
authors.forename: Marc
authors.initials: M
authors.lastname: Buffet
authors.forename: Tereza
authors.initials: T
authors.lastname: Coman
authors.forename: Norbert-Claude
authors.initials: NC
authors.lastname: Gorin
authors.forename: Paul
authors.initials: P
authors.lastname: Coppo
authors.forename: Laurent
authors.initials: L
authors.lastname: Garderet
authors.forename: Sandra
authors.initials: S
authors.lastname: Malak
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D016879:Salvage Therapy; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin